Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2007
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847542A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
10/24/2007EP1847533A1 Six-membered heterocyclic compound and the use thereof
10/24/2007EP1847267A2 Method of photodynamic diagnosis for vascular diseases
10/24/2007EP1847182A2 Foodstuffs or dietary supplements containing flavonoid derivates
10/24/2007EP1846428A1 Anti-inflammatory conjugates of macrolides and coumarins
10/24/2007EP1846404A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
10/24/2007EP1846403A1 Azabicyclo derivatives as anti-inflammatory agents
10/24/2007EP1846397A1 Novel heterocyclic benzoy[c]chromene derivatives useful as modulators of the estrogen receptors
10/24/2007EP1846387A2 Bis-(coumarin) compounds with anti-inflammatory activity
10/24/2007EP1846370A2 2-METHYLENE-19-NOR-1&agr;-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES
10/24/2007EP1846369A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
10/24/2007EP1846364A1 New potent and selective ligands of cannabinoid receptors
10/24/2007EP1846003A1 9a-carbamoyl and thiocarbamoyl azalides with anti-inflammatory activity
10/24/2007EP1845987A2 Treatment of inflammatory disorders with praziquantel
10/24/2007EP1845976A2 Use of inhibitors of soluble epoxide hydrolase to synergize activity of cox and 5-lox inhibitors
10/24/2007EP1845957A1 Method for producing a drug extract that contains hydroxystilbene
10/24/2007EP1432728A4 Methods and compositions for treating inflammatory disorders
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007EP1207860B1 Controlled release pellet formulation
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007CN101060863A Modulation of neuroglia-derived BDNF in the treatment and prevention of pain
10/24/2007CN101057964A Application of marasmius androsaceus glycoprotein in medicine making
10/24/2007CN101057952A Medicinal composition for treating dysmenorrhoea and its preparation method and application
10/24/2007CN101057951A Plaster for auxiliary curing rheumatoid disease and its preparing method
10/24/2007CN101057927A Medicinal composition and its preparation method and quality control method
10/24/2007CN101057911A Health care wine with curative effect
10/24/2007CN101057902A Medicine and its quality control method
10/24/2007CN101057893A Traditional Chinese medicine for treating osteoproliferation, rheumatoid and rheumatic arthritis and sciatica
10/24/2007CN101057879A Microwave extraction method for total flavones of sacandra glabra
10/24/2007CN101057866A Method for preparing 'kelike' capsule
10/24/2007CN101057865A Method for preparing 'youkadan' granule
10/24/2007CN101057845A Bulleyaconitin A dry emulsion and its preparation method and application
10/24/2007CN101057828A Injection for treating rheumatoid disease
10/24/2007CN101057621A Preparation method for chimonanthea tea
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
10/24/2007CN100344632C 稠合的呋喃化合物 Fused furan compound
10/24/2007CN100344611C 4-nitro-2-[(4'-methoxyl)-phenoxy]-toluenesulfonamide derivant and its medical uses
10/24/2007CN100344300C Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method
10/24/2007CN100344299C Medicine for treating woman's dysmenorrhea and preparing process thereof
10/24/2007CN100344288C Compound pain-stopping and inflammation-diminishing anticarcinogen capsule
10/23/2007US7285687 Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease
10/23/2007US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285676 Synthesis of chiral 2-alkyl amino acids
10/23/2007US7285670 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methyl-thiazole-4(S)-carboxylic acid by coupling a mono- or polyalkoxybenzonitrile with a cysteine ester and alkylating the thiazoline ring at the 4-carbon position; preferably a phase transfer agent such as N-9-anthracenylmethylcinchonidinium chloride is used
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285642 Composition and method for modulating dendritic cell-T cell interaction
10/23/2007US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/23/2007US7285561 Imidazo-substituted compounds as p38 kinase inhibitors
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285559 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007CA2263889C P-selectin ligand proteins
10/23/2007CA2248266C Immunosuppressive compounds and methods
10/23/2007CA2177961C Use of dimeticone for treating aphthae and stomatitis
10/18/2007WO2007118041A1 Compounds which modulate the cb2 receptor
10/18/2007WO2007117995A2 Kinase inhibitors
10/18/2007WO2007117577A2 High affinity human antibodies to human il-18 receptor
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007116901A1 Novel arylamide derivative
10/18/2007WO2007116432A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same
10/18/2007WO2007116287A1 Pharmaceutical composition that comprises an analgesic and vitamins
10/18/2007WO2007115933A1 Thiazolyldihydroindazoles
10/18/2007WO2007115932A1 Thiazolyl-dihydroquinazolines
10/18/2007WO2007115930A1 Thiazolyldihydroindazoles
10/18/2007WO2007115929A1 Thiazolyl-dihydroquinazolines
10/18/2007WO2007115822A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions
10/18/2007WO2007115713A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
10/18/2007WO2007115670A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007WO2007115473A1 Pyrrole derivatives inhibitors, their curative uses
10/18/2007WO2007115403A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007098252A3 Methods and compositions for treating hyperalgesia
10/18/2007WO2007083190A3 Water insoluble helichrysum extract, process for preparing the same and uses thereof
10/18/2007WO2007076228A8 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
10/18/2007WO2007059507A3 Compositions comprising lipoxygenase inhibitors and cyclodextrin
10/18/2007WO2007035494A3 Inducing expression of puma to reduce joint inflammation in the treatment of arthritis
10/18/2007US20070244303 comprising an Fc region derived from a human IgG heavy chain, wherein the Fc region lacks effector function; for the reduction of a deleterious immune response; idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244138 antiinflammatory agents
10/18/2007US20070244086 3-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
10/18/2007US20070244080 Method for Treatment of Inflammatory Disorders Using Triptolide Compounds
10/18/2007US20070244068 2',3'-O-methylenestyryl-5'-alpha-(carboxymethylenephosphono)-N6-ethylaminocarbonyl-adenosine phosphate; modified mononucleoside phosphate by attaching degradation-resistant substituent on terminal phosphate; increase rate & total amount of mucin secretion; epithelial tissue, platelet aggregation diseases
10/18/2007US20070244060 Therapeutic Agent for Autoimmune Disease
10/18/2007US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine.
10/18/2007DE69233686T2 Heteoaryl-Piperidine und Piperazine und ihre Anwendung als antipsychotisches und analgetisches Mittel Heteoaryl-piperidines and piperazines and their use as antipsychotic and analgesic agent
10/18/2007DE102006017827A1 Neue kristalline Verbindungen New crystalline compounds
10/18/2007CA2659767A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same
10/18/2007CA2651898A1 Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
10/18/2007CA2649194A1 Pharmaceutical composition that comprises an analgesic and vitamins
10/18/2007CA2649000A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007CA2648330A1 Anti-ccr2 antibody depletes monocytes to treat multiple sclerosis and rheumatoid arthritis
10/18/2007CA2647434A1 Thiazolyldihydroindazoles
10/18/2007CA2647295A1 Thiazolyldihydroindazoles
10/18/2007CA2646571A1 Thiazolyl-dihydroquinazolines
10/18/2007CA2643863A1 Compounds which modulate the cb2 receptor
10/18/2007CA2643011A1 Quinolones useful as inducible nitric oxide synthase inhibitors
1 ... 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 ... 1272